Work

Analysis of Cognitive Adverse Events in Two Phase III Conversion-to-Eslicarbazepine Acetate (ESL) Monotherapy Trials (P5.277)

Year: 2018

Type: article

Source: Neurology

DOI: 10.1212/wnl.90.15_supplement.p5.277

Authors: Jay Salpekar, Cynthia Harden, David Loring, Todd Grinnell, David Cantu, JungAh Jung, David Blum

Institutions: Kennedy Krieger Institute, Johns Hopkins University, Emory University, Sunovion (United States)

Language: English

Topic: Epilepsy research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2806079983

FWCI: 0.197

Cites:

Cited by: 1

Related to: 10